SNES:NSC-SenesTech Inc. (USD)

COMMON STOCK | Specialty Chemicals | NASDAQ Capital Market

Last Closing

USD 2.75

Change

+0.07 (+2.61)%

Market Cap

USD 0.09B

Volume

4.42K

Analyst Target

USD 4.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

SenesTech Inc is a biotech platform and research company. The Company is engaged in developing technology for managing animal pest populations through fertility control.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-29 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap
LIN Linde plc Ordinary Shares

N/A

USD 215.48B
BCPC Balchem Corporation

N/A

USD 5.28B
WDFC WD-40 Company

N/A

USD 3.04B
HWKN Hawkins Inc

N/A

USD 2.63B
IOSP Innospec Inc

N/A

USD 2.27B
CLMT Calumet Specialty Products Par..

N/A

USD 1.07B
GEVO Gevo Inc

N/A

USD 0.31B
HDSN Hudson Technologies Inc

N/A

USD 0.31B
MNTK Montauk Renewables Inc

N/A

USD 0.27B
LWLG Lightwave Logic Inc

N/A

USD 0.11B

ETFs Containing SNES

DXSD:F 5.56 % 0.00 %

N/A

N/A
DXSD:XETRA 5.56 % 0.00 %

N/A

N/A
RECY:LSE WisdomTree Recycling Deca.. 5.34 % 0.00 %

N/A

USD 2.56M
CBUD:XETRA 3.34 % 0.00 %

N/A

N/A
IESE:SW iShares MSCI Europe SRI U.. 3.19 % 0.00 %

N/A

USD 3.45B
ASWA:XETRA European Green Deal UCITS.. 2.31 % 0.00 %

N/A

USD 9.35M
EYED:LSE iShares MSCI Europe Energ.. 2.22 % 0.00 %

N/A

N/A
ENGE:LSE SPDR® MSCI Europe Energy.. 1.81 % 0.00 %

N/A

N/A
CRAK VanEck Oil Refiners ETF 0.00 % 0.60 %

N/A

USD 0.02B
ENGY:LSE SPDR® MSCI Europe Energy.. 0.00 % 0.00 %

N/A

N/A
IESG:LSE iShares MSCI Europe SRI U.. 0.00 % 0.00 %

N/A

N/A
XSER:LSE 0.00 % 0.00 %

N/A

N/A
IUSK:F iShares MSCI Europe SRI U.. 0.00 % 0.00 %

N/A

N/A
SMLU:F 0.00 % 0.00 %

N/A

N/A
SPYN:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

N/A

N/A
IUSK:XETRA iShares MSCI Europe SRI U.. 0.00 % 0.00 %

N/A

N/A
OIGS:XETRA Multi Units Luxembourg - .. 0.00 % 0.00 %

N/A

N/A
36B3:XETRA iShares MSCI Europe SRI U.. 0.00 % 0.00 %

N/A

N/A
36B3:F iShares MSCI Europe SRI U.. 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Specialty Chemicals) Market Performance vs. Exchange (NASDAQ Capital Market)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -16.92% 68% D+ 33% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -16.92% 68% D+ 33% F
Trailing 12 Months  
Capital Gain -62.33% 40% F 13% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -62.33% 40% F 13% F
Trailing 5 Years  
Capital Gain -99.94% 8% B- 1% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -99.94% 8% B- 1% F
Average Annual (5 Year Horizon)  
Capital Gain 247.01% 95% A 96% N/A
Dividend Return 247.01% 95% A 96% N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 2,973.69% 11% F 3% F
Risk Adjusted Return 8.31% 47% F 45% F
Market Capitalization 0.09B 10% F 5% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Underpriced on free cash flow basis

The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative earnings

The company had negative total earnings in the most recent four quarters.